Sino Biopharmaceutical Limited
SBMFF | OTC
$0.65
-$0.05 (-7.28%)
At close: Sep 11, 2026, 04:00 PM ET
Market Data
Market Cap $12.47B
Enterprise Value $80.96B
Beta 0.61
Average Volume N/A
Shares Outstanding (Diluted) 18.05B
Shares Change YoY 0.13%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M 0.0%
Price Change 3M 2.7%
Price Change 6M -21.7%
Price Change YTD -25.5%
Price Change 1Y -43.5%
Price Change 3Y 75.7%
Price Change 5Y -21.8%
1M CAGR (ann.) 11.2%
1Y CAGR (ann.) -40.2%
5Y CAGR (ann.) -1.7%
All-Time CAGR 6.9%
Valuation
PE Ratio 34.96
Forward PE N/A
PEG Ratio -0.85
Forward PEG N/A
PS Ratio 2.41
Forward PS 2.00
PB Ratio 2.42
P/FCF Ratio 15.70
P/Adj. FCF Ratio 16.34
P/OCF Ratio 13.37
EV/Sales 2.40
EV/EBIT 8.53
EV/EBITDA 7.78
EV/FCF 15.68
Earnings Yield 3.0%
FCF Yield 6.6%
Adj. FCF Yield 6.4%
Financial Health
Net Debt ¥2.22B
Total Debt ¥17.17B
Cash & Short-Term Investments ¥27.58B
Total Assets ¥83.21B
Current Ratio 1.63
Quick Ratio 1.56
Debt / Equity Ratio 0.53
Debt / EBITDA 1.65
Debt / FCF 3.33
OCF / Debt 0.36
Interest Coverage 0.00
Altman Z-Score 2.40
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 82.4%
Operating Profit Margin 29.8%
EBITDA Margin 30.9%
Net Profit Margin 7.1%
FCF Margin 15.3%
Adj. FCF Margin 14.7%
SBC / Revenue 0.6%
SBC Impact (per share) -3.9%
Returns
Return on Assets 2.9%
Return on Equity 7.6%
Return on Invested Capital 12.0%
Return on Capital Employed 17.9%
Return on Tangible Assets 3.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.0%
Revenue CAGR 5Y 5.6%
Revenue CAGR 10Y 9.8%
EPS CAGR 3Y 2.7%
EPS CAGR 5Y -2.8%
EPS CAGR 10Y 3.8%
FCF CAGR 3Y 18.5%
FCF CAGR 5Y 17.0%
FCF CAGR 10Y 25.3%
Analyst Forecasts
Analyst Rating N/A
Analyst Count N/A
EPS Growth Next 3Y 24.4%
Revenue Growth Next 3Y 11.3%
Earnings Date Mar 31, 2027
EPS Estimate (next Q) $0
EPS Growth Est (next Q) 839.9%
Revenue Est (next Q) $372.78M
Revenue Growth Est (next Q) 22.8%
Fair Value Estimates
Graham Number $0.40
Graham Upside -38.5%
Lynch Fair Value $0.09
Lynch Upside -86.2%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥6.13B
Free Cash Flow ¥5.16B
Adj. Free Cash Flow ¥4.96B
FCF Per Share $0.29
OCF Per Share $0.34
OCF/S Ratio 18.2%
Income Statement
Revenue ¥33.7B
Gross Profit ¥27.78B
Operating Income ¥10.03B
EBITDA ¥10.41B
Net Income ¥2.39B
EPS (Diluted) $0.13
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Dividends
Annual Dividend $0.02
Dividend Yield 3.08%
Payout Ratio 11.8%
FCF Payout Ratio 29.1%
Adj. FCF Payout Ratio 30.3%
Dividend Growth (YoY) 33.0%
Pay Frequency Semi-Annual
Ex-Dividend Date Sep 2, 2026
Add to Watchlist
Select watchlists to add or remove SBMFF